NEW YORK, Sep. 8, 2009 (PRNewswire-Asia-FirstCall) -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the Company's participation in the following conferences:
-- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009
in Boston, MA. Management will meet with institutional investors
throughout the day.
-- Morgan Stanley Global Healthcare Unplugged Conference, to be held
September 14-15, 2009 in New York City. Management will meet with
institutional investors throughout both days.
-- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices
Conference, to be held September 15-17, 2009 in London. Management will
present at 1:45pm London Time on September 16, 2009 and meet with
institutional investors throughout all three days. A live webcast of
the presentation will be available via the Company's website at
http://www.bioaobo.com/ .
-- Susquehanna Financial Group Third Annual Beijing Management Summit, to
be held September 16-17, 2009 in Beijing, China. Management will speak
on a panel discussion entitled, "China Pharma/Biotech Panel
Participants," scheduled from 1:05-2:10pm Beijing Time on September 16,
2009. In addition, management will also present at 9:45am Beijing Time
on September 16, 2009 and meet with institutional investors throughout
both days.
For further details, please contact your respective institutional sales representative.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.
SOURCE American Oriental Bioengineering, Inc.
